A new study, published by the Cancer Prevention Research, by researchers at Fred Hutchinson Cancer Research Center has determined that weight loss in combination with vitamin D supplementation, reduces chronic inflammation linked to cancer, chronic disease. Vitamin D is a steroid hormone that has different functions beyond its widely recognized role in regulating calcium levels and bone metabolism. Vitamin D receptors are found in more than 30 cell types. Obese people have a chronic state of chronic inflammation caused by sustained upregulation of the inflammatory response occurs because fat tissue continually produces cytokines, molecules that are usually only present for a short time, while the body is fighting infection, for example.
The research study participants consisted of 218 overweight, postmenopausal women who had insufficient levels of vitamin D at the beginning of the study. The women then took part in a 12-month diet and exercise program (including 45 minutes of moderate-to-vigorous exercise five days a week). Fifty percent of the study participants were randomly selected to receive 2,000 IU of vitamin D daily for the duration of the year-long trial, and the other half received an identical-appearing placebo, or dummy vitamin. The level of inflammation was measured by analyzing biomarkers at the beginning and end of study. The researchers then compared changes in these levels between the two groups.
“We know from our previous studies that by losing weight, people can reduce their overall levels of inflammation, and there is some evidence suggesting that taking vitamin D supplements can have a similar effect if one has insufficient levels of the nutrient,” said lead and corresponding author Catherine Duggan, Ph.D., a principal staff scientist in the Public Health Sciences Division at Fred Hutch. However, it has not been known whether combining the two — weight loss and vitamin D — would further boost this effect. “It’s the first study to test whether adding vitamin D augments the considerable effect of weight loss on inflammatory biomarkers,” she said.
The findings revealed that at the end end of the study, all of the participants had reduced levels of inflammation, regardless of whether they took vitamin D. However, those who saw the most significant decline in markers of inflammation were those who took vitamin D and lost 5 to 10 percent of their baseline weight. The women who lost weight in conjunction with vitamin D supplementation had a 37 percent reduction in a pro-inflammatory cytokine called interleukin-6, or IL-6, as compared to those in the placebo group, who saw a 17.2 percent reduction in IL-6. Elevated levels of interleukin-6 are associated with an increased risk of developing certain cancers and diabetes and may be implicated as a cause of depression.
“We were quite surprised to see that vitamin D had an effect on an inflammation biomarker only among women who lost at least 5 percent of their baseline weight,” Duggan said. “That suggests vitamin D can augment the effect of weight loss on inflammation.”
“It is thought that this state of chronic inflammation is pro-tumorigenic, that is, it encourages the growth of cancer cells,” she said. There is also some evidence that increased body mass “dilutes” vitamin D, possibly by sequestering it in fat tissue.
“Weight loss reduces inflammation, and thus represents another mechanism for reducing cancer risk,” Duggan said. “If ensuring that vitamin D levels are replete, or at an optimum level, can decrease inflammation over and above that of weight loss alone, that can be an important addition to the tools people can use to reduce their cancer risk.”
C. Duggan, J. de Dieu Tapsoba, C. Mason, I. Imayama, L. Korde, C.-Y. Wang, A. McTiernan. Effect of Vitamin D3 Supplementation in Combination with Weight Loss on Inflammatory Biomarkers in Postmenopausal Women: A Randomized Controlled Trial. Cancer Prevention Research, 2015; DOI: 10.1158/1940-6207.CAPR-14-0449